Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS

V Fleischer, M Friedrich, A Rezk… - Multiple Sclerosis …, 2018 - journals.sagepub.com
Background: The effect of dimethyl fumarate (DMF) on circulating lymphocyte subsets and
their contribution as predictors of clinical efficacy have not yet been investigated in multiple …
被引用次数：64 相关文章

Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS.

V Fleischer, M Friedrich, A Rezk… - Multiple Sclerosis …, 2018 - search.ebscohost.com
Background: The effect of dimethyl fumarate (DMF) on circulating lymphocyte subsets and
their contribution as predictors of clinical efficacy have not yet been investigated in multiple …
[PDF] researchgate.net

[PDF][PDF] Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS

V Fleischer, M Friedrich, A Rezk, U Bühler… - Multiple Sclerosis …, 2017 - researchgate.net
Background: The effect of dimethyl fumarate (DMF) on circulating lymphocyte subsets and
their contribution as predictors of clinical efficacy have not yet been investigated in multiple …

Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS

V Fleischer, M Friedrich, A Rezk… - Multiple sclerosis …, 2018 - pubmed.ncbi.nlm.nih.gov
Background The effect of dimethyl fumarate (DMF) on circulating lymphocyte subsets and
their contribution as predictors of clinical efficacy have not yet been investigated in multiple …

Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS.

V Fleischer, M Friedrich, A Rezk, U Bühler… - Multiple Sclerosis …, 2017 - europepmc.org
Background The effect of dimethyl fumarate (DMF) on circulating lymphocyte subsets and
their contribution as predictors of clinical efficacy have not yet been investigated in multiple …